Newsroom

Case Report: Radiopharmaceutical extravasation, radiation paranoia, and chilling effect

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has stated they oppose reporting significant extravasations to patients or authorities, arguing such incidents are rare and not severe. They warn against causing unnecessary fear or reluctance toward nuclear medicine due to “radiation paranoia.” However, this stance seems at odds with actual clinical experiences, including a severe case at a center focused on minimizing radiopharmaceutical extravasations. Transparency with patients, contrary to causing fear, has been found to foster trust. Ignoring the real frequency and severity of extravasations might undermine patient confidence in the nuclear medicine community. Full Text

Lucerno Dynamics and Carilion Clinic Announce Radiotherapy Administration Milestone

Lucerno announced the worldwide first use of Lara® Real-Time Visualization (RTV) in a clinical setting at Carilion Roanoke Memorial Hospital, Carilion Clinic’s flagship facility. Press Release

House and Senate Act on Nuclear Medicine Safety. Appropriations bills passed by each chamber include important provisions to protect safety and quality of care for patients

Lucerno praised both the U.S. House of Representatives and the U.S. Senate for passing legislation that includes important provisions regarding a patient safety issue that affects thousands of patients every year and pushing the U.S. Nuclear Regulatory Commission (NRC) and Veterans Health Administration (VHA) to put patients first. Press Release

Radiopharmaceutical administration practices—Are they best practice?

The nuclear medicine community has stated that they are using best practices to gain venous access and administer radiopharmaceuticals, and therefore do not contribute to extravasations. We tested this hypothesis qualitatively and quantitatively by evaluating four different perspectives of current radiopharmaceutical administration practices and compared them to the gold standard of pharmaceutical administration techniques. Full Text

To tell or not to tell … the patient about potential harm

Tim Bartholow, a family practitioner and former chief medical officer for a not-for-profit payer, reflects on clinicians’ responsibility concerning extravasations. He believes it’s essential to be aware of known potential harm and to disclose such risks to patients both before an incident and if harm has indeed occurred. Full Text

Critique and discussion of “Multicenter evaluation of frequency and impact of activity infiltration in PET imaging, including microscale modeling of skin-absorbed dose”

On May 25, 2023, the Journal of Nuclear Medicine (JNM) published an article ahead-of-print entitled “Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose” … There are, however, several problems with the work that raise questions about its conclusions. The methods are not well described, the results contain errors, and the peer-review process for this manuscript appears to have lacked rigor. Full Text

Radiopharmaceutical extravasations: a twenty year mini-review

This mini-review will examine the literature of the last twenty years to summarize the history of radiopharmaceutical extravasations, determine key trends in imaging and therapies, and highlight critical gaps in research that currently exist. Full Text

The decision to reimage following extravasation in diagnostic nuclear medicine

To provide high quality service, nuclear medicine departments as well as the interpreting radiologist physicians should be cognizant of the possible need to repeat studies which have been affected by an extravasation. Full Text

Active monitoring improves radiopharmaceutical administration quality

Our findings suggest that active monitoring and the associated display of results are critical to quality improvement efforts to reduce and sustain radiopharmaceutical extravasation rates. Full Text

Transparency – a patient-centric view on radiopharmaceutical extravasations

From the patient perspective, transparency regarding extravasations is essential to improving care, ensuring radiation protection, reducing health inequities, and untangling the deeply disturbing and irregular relationship between the nuclear medicine community and their regulating body, The U.S. Nuclear Regulatory Commission. Full Text

Lucerno Dynamics Submits ‘Information Correction Request’ to Address NRC Extravasation Reporting Decision

Lucerno informed the US Nuclear Regulatory Commission (NRC) that a key document used to develop the patient injury reporting criterion did not meet NRC’s requirements for information quality. Asks NRC to immediately issue Interim Staff Guidance. Press Release

Extravasation of radiopharmaceuticals: Why report?

Steps can be taken by radiation protection personnel at medical institutions to educate practitioners and staff about extravasations, their risks and what steps can be taken to reduce their occurrence. Further research needs to be performed to better understand the incidence rate, categorization, causes, and methods of prevention. Full text